GlassScriptPhysician profile
Peter Ward Ketch
NPI 1528529948
$489.08
in general payments reported to CMS, 2019-2025
10 companies · $76.98 in 2025
The $76.98 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.20 · 2023: $280 · 2024: $48.34 · 2025: $76.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $204.05 | 2023-2024 | Da Vinci Surgical System |
| Aadi Bioscience, INC. | $50.17 | 2023 | Fyarro |
| Astrazeneca Pharmaceuticals LP | $46.37 | 2022 | |
| Glaxosmithkline, LLC. | $38.80 | 2024-2025 | Zejula, Jemperli |
| Seagen INC. | $37.83 | 2022 | |
| Sumitomo Pharma America, INC. | $35.18 | 2023 | Gemtesa |
| Genentech USA, INC. | $23.22 | 2025 | Itovebi |
| Boston Scientific Corporation | $20.27 | 2023 | Upsylon |
| Medical Device Business Services, INC. | $18.19 | 2025 | Enseal |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ketch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.